IDeA Clinical and Translational Research Network (CTR-N) Award (P50 - Clinical Trial Optional)

The IDeA Clinical and Translational Research Network (CTR-N) Award (P50 - Clinical Trial Optional) is a grant that aims to increase the capacity for clinical and translational research in states or jurisdictions eligible for IDeA (Institutional Development Award). The initiative also seeks to improve these investigators' chances of receiving funding for their research. Through the grant, a cooperative agreement is provided to either statewide or cross-state regional networks, aiming to meet several objectives.

First, the grant supports the development and improvement of infrastructure and human resources that are needed to conduct clinical and translational research within IDeA-eligible locations.

Second, it aims to enhance clinical and translational studies that tackle a variety of health challenges experienced by populations within these eligible locations.

Lastly, the initiative looks to encourage and arrange cooperation in clinical and translational research within an IDeA-CTR network and between other institutions. This financial support is part of the Funding Opportunity Announcement (FOA) provided by the funding body.